(2R,4R)-1-(1-(4-Chlorophenyl)-3,3-difluorocyclobutane-1-carbonyl)-4-fluoro-N-(1H-pyrazolo[4,3-b]pyridin-5-yl)pyrrolidine-2-carboxamide

ID: ALA5220994

Chembl Id: CHEMBL5220994

PubChem CID: 167312228

Max Phase: Preclinical

Molecular Formula: C22H19ClF3N5O2

Molecular Weight: 477.87

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(Nc1ccc2[nH]ncc2n1)[C@H]1C[C@@H](F)CN1C(=O)C1(c2ccc(Cl)cc2)CC(F)(F)C1

Standard InChI:  InChI=1S/C22H19ClF3N5O2/c23-13-3-1-12(2-4-13)21(10-22(25,26)11-21)20(33)31-9-14(24)7-17(31)19(32)29-18-6-5-15-16(28-18)8-27-30-15/h1-6,8,14,17H,7,9-11H2,(H,27,30)(H,28,29,32)/t14-,17-/m1/s1

Standard InChI Key:  YWMDIJGVLFEWKQ-RHSMWYFYSA-N

Alternative Forms

  1. Parent:

    ALA5220994

    ---

Associated Targets(Human)

EP300 Tchem Histone acetyltransferase p300 (1259 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EP300 Tchem CREB-binding protein/Histone acetyltransferase p300 (392 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CREBBP Tchem CREB-binding protein (1602 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KAT7 Tbio Histone acetyltransferase KAT7 (12 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KAT2A Tchem Histone acetyltransferase GCN5 (14285 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KAT6B Tchem Histone acetyltransferase KAT6B (12 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KAT5 Tchem Histone acetyltransferase KAT5 (85 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KAT2B Tchem Histone acetyltransferase PCAF (884 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 477.87Molecular Weight (Monoisotopic): 477.1179AlogP: 3.86#Rotatable Bonds: 4
Polar Surface Area: 90.98Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 8.90CX Basic pKa: 1.33CX LogP: 2.78CX LogD: 2.77
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.60Np Likeness Score: -1.26

References

1. Tian X, Suarez D, Thomson D, Li W, King EA, LaFrance L, Boehm J, Barton L, Di Marco C, Martyr C, Thalji R, Medina J, Knight S, Heerding D, Gao E, Nartey E, Cecconie T, Nixon C, Zhang G, Berrodin TJ, Phelps C, Patel A, Bai X, Lind K, Prabhu N, Messer J, Zhu Z, Shewchuk L, Reid R, Graves AP, McHugh C, Mangatt B..  (2022)  Discovery of Proline-Based p300/CBP Inhibitors Using DNA-Encoded Library Technology in Combination with High-Throughput Screening.,  65  (21.0): [PMID:36302181] [10.1021/acs.jmedchem.2c00670]

Source